2022. Pharmacotherapeutic and laboratory profile analysis of patients with secondary hyperparathyroidism submitted to parathyroidectomy. Research, Society and Development. 11, 5 (Apr. 2022), e16511527949. DOI:https://doi.org/10.33448/rsd-v11i5.27949.